Key references: Management of osteoporosis in the absence of fracture

Ebeling P, Center J, Clifton-Bligh R, Cooper M, Ewald D, Singh M, et al. Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age. 2nd ed. Melbourne: The Royal Australian College of General Practitioners; 2017. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/osteoporosis
Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, et al. Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 2018;379(25):2407–16. https://www.ncbi.nlm.nih.gov/pubmed/30575489
Scottish Intercollegiate Guidelines Network (SIGN) Management of osteoporosis and the prevention of fragility fractures [SIGN 142]. Edinburgh: SIGN; 2015. https://www.sign.ac.uk/sign-142-management-of-osteoporosis-and-the-prevention-of-fragility-fractures.html
Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 2018;391(10122):741–7. https://www.ncbi.nlm.nih.gov/pubmed/29254858
Sheu A, Diamond T. Secondary osteoporosis. Aust Prescr 2016;39(3):85–7. https://www.ncbi.nlm.nih.gov/pubmed/27346916